(HealthDay News) – Stress urinary incontinence treatment with a distal urethral polypropylene sling procedure is associated with excellent long-term efficacy and durability.
Lisa Rogo-Gupta, MD, of the Geffen School of Medicine at the University of California in Los Angeles, and colleagues conducted a prospective study involving 69 consecutive patients who underwent a distal urethral polypropylene sling procedure for the treatment of stress urinary incontinence. Long-term follow-up data at a minimum of 11 years were available for 30 patients (mean age at follow-up, 73 years).
Of the patients lost to follow-up, 10 were deceased and five were cognitively impaired. At follow-up, the researchers found that 48% of patients reported no symptoms of stress urinary incontinence and 63% reported not being bothered by stress urinary incontinence. Overall, symptoms improved an average of 64% at 11 years, compared with 81% at five years. Based on symptom scores, 82% of patients were rated as successes, while 80% were rated as successes based on bother scores.
“The distal urethral polypropylene sling procedure has excellent long-term durability in the treatment of stress urinary incontinence, in addition to low morbidity and low cost as previously described,” the authors write. “When choosing an anti-incontinence procedure, durability should be considered in light of patient age given that the theoretical advantages of long-term durability are limited by cognitive decline and mortality.”
One author disclosed financial ties to Astellas and Allergan.